BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15982530)

  • 1. Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor.
    Ahn YH; Bensadoun JC; Aebischer P; Zurn AD; Seiger A; Björklund A; Lindvall O; Wahlberg L; Brundin P; Kaminski Schierle GS
    Brain Res Bull; 2005 Jul; 66(2):135-42. PubMed ID: 15982530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.
    Sautter J; Tseng JL; Braguglia D; Aebischer P; Spenger C; Seiler RW; Widmer HR; Zurn AD
    Exp Neurol; 1998 Jan; 149(1):230-6. PubMed ID: 9454632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
    Yurek DM
    Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
    Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
    Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
    Strömberg I; Björklund L; Johansson M; Tomac A; Collins F; Olson L; Hoffer B; Humpel C
    Exp Neurol; 1993 Dec; 124(2):401-12. PubMed ID: 7904571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
    Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
    Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease.
    Shingo T; Date I; Yoshida H; Ohmoto T
    J Neurosci Res; 2002 Sep; 69(6):946-54. PubMed ID: 12205688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.
    Törnqvist N; Björklund L; Almqvist P; Wahlberg L; Strömberg I
    Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
    Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
    Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wen Ji Y; Hayase H; Hamada H; Borlongan CV; Date I
    Brain Res; 2005 Aug; 1053(1-2):10-8. PubMed ID: 16045899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long distance selective fiber outgrowth of transplanted hNT neurons in white matter tracts of the adult rat brain.
    Baker KA; Mendez I
    J Comp Neurol; 2005 Jun; 486(4):318-30. PubMed ID: 15846787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival of embryonic porcine dopaminergic neurons in coculture with a conditionally immortalized GDNF-producing hippocampal cell line.
    Meyer M; Johansen J; Gramsbergen JB; Johansen TE; Zimmer J
    Exp Neurol; 2000 Jul; 164(1):82-93. PubMed ID: 10877918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
    Quinn M; Mukhida K; Sadi D; Hong M; Mendez I
    Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
    Cunningham LA; Su C
    Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons.
    Ostenfeld T; Tai YT; Martin P; Déglon N; Aebischer P; Svendsen CN
    J Neurosci Res; 2002 Sep; 69(6):955-65. PubMed ID: 12205689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of GDNF on differentiation of cultured ventral mesencephalic dopaminergic and non-dopaminergic calretinin-expressing neurons.
    Schaller B; Andres RH; Huber AW; Meyer M; Pérez-Bouza A; Ducray AD; Seiler RW; Widmer HR
    Brain Res; 2005 Mar; 1036(1-2):163-72. PubMed ID: 15725414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice.
    Larsen KE; Benn SC; Ay I; Chian RJ; Celia SA; Remington MP; Bejarano M; Liu M; Ross J; Carmillo P; Sah D; Phillips KA; Sulzer D; Pepinsky RB; Fishman PS; Brown RH; Francis JW
    Brain Res; 2006 Nov; 1120(1):1-12. PubMed ID: 17020749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grafting of encapsulated genetically modified cells secreting GDNF into the striatum of parkinsonian model rats.
    Date I; Shingo T; Yoshida H; Fujiwara K; Kobayashi K; Takeuchi A; Ohmoto T
    Cell Transplant; 2001; 10(4-5):397-401. PubMed ID: 11549061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Agrawal AK
    Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.